Discovery of Novel Trypanothione Reductase Inhibitors through Pharmacophore Modeling, virtual Screening and Molecular Dynamics Simulations. New insights for Human African Trypanosomiasis
EVANS, E. M.; Taofeek, O. O.; Gwira, T. M.; Morang'a, C. M.; Musyoka, T. M.; Nyanjom, S. G.
Show abstract
Human African Trypanosomiasis (HAT), caused by Trypanosome brucei, remains a critical health concern, with treatments such as Melarsoprol hampered by toxicity and resistance. To address this, we aimed to identify inhibitors targeting Trypanothione Reductase (T.b TR), a key enzyme in the parasites survival. A pharmacophore model was derived from Melarsoprol and validated using Receiver Operating Characteristic (ROC) curves and Enrichment Factor (EF). Virtual screening of compound libraries identified two promising candidates, VS-1 and VS-2, based on superior docking scores. Subsequent molecular dynamics simulations confirmed the stability of the ligand-enzyme complexes, while binding free energy calculations revealed strong binding affinities for VS-1 and VS-2. Per-residue decomposition pointed critical interactions with active site residues, including MET 260, ASN 130, and HIS 128, contributing to the compounds stability and activity. These findings suggest that VS-1 and VS-2 are potential inhibitors of T.b TR, with better efficacy than Melarsoprol. However, further in vitro studies, including IC50 determination, cell cycle analysis, and morphological assays, are essential to confirm the therapeutic potential of these compounds for the treatment of HAT.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 97%
- De novo drug designing coupled with brute force screening and structure guided lead optimization gives highly specific inhibitor of METTL3: a potential cure for Acute Myeloid Leukaemia 97%
- Molecular Elucidation of Pancreatic Elastase Inhibition by Baicalein 96%
Similar papers in this journal
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 98%
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 98%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 98%
Similar papers in this journal
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 97%
- Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design 97%
- Chalcogen derivatives for the treatment of African trypanosomiasis: biological evaluation of thio and seleno- semicarbazones and their azole derivatives 96%
Similar papers in this journal
Similar papers in this journal
- Mechanistic insights into the Japanese Encephalitis Virus RNA dependent RNA polymerase protein inhibition by bioflavonoids from Azadirachta indica 96%
- Mechanistic insights into the deleterious role of nasu-hakola disease associated TREM2 variants 95%
- Novel Peptide Inhibitor of Human Tumor Necrosis Factor-α has Antiarthritic Activity 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.